Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25526-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- SLC35F2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated SLC35F2 antibody (Cat. #25526-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references E3 ubiquitin ligase APC/C(Cdh1) regulates SLC35F2 protein turnover and inhibits cancer progression in HeLa cells.
βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells.
USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.
Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.
Colaco JC, Chandrasekaran AP, Karapurkar JK, Gowda DAA, Birappa G, Rajkumar S, Suresh B, Ko N, Hong SH, Oh SJ, Kim KS, Ramakrishna S
Biochimica et biophysica acta. General subjects 2023 Nov;1867(11):130454
Biochimica et biophysica acta. General subjects 2023 Nov;1867(11):130454
βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells.
Colaco JC, Chandrasekaran AP, Karapurkar JK, Birappa G, Rajkumar S, Gowda DAA, Suresh B, Lee J, Singh V, Hong SH, Kim KS, Ramakrishna S
Biochemical and biophysical research communications 2023 Nov 19;682:27-38
Biochemical and biophysical research communications 2023 Nov 19;682:27-38
USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.
Chandrasekaran AP, Kaushal K, Park CH, Kim KS, Ramakrishna S
Theranostics 2021;11(20):9752-9771
Theranostics 2021;11(20):9752-9771
Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.
Chen M, Gao X, Huang D, Wang S, Zheng L, Chen Y, Wen X, Gao Y, Cao H, Zhang S
OncoTargets and therapy 2019;12:10771-10786
OncoTargets and therapy 2019;12:10771-10786
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.
Nyquist MD, Corella A, Burns J, Coleman I, Gao S, Tharakan R, Riggan L, Cai C, Corey E, Nelson PS, Mostaghel EA
Molecular cancer research : MCR 2017 May;15(5):521-531
Molecular cancer research : MCR 2017 May;15(5):521-531
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The SLC35F2 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human SLC35F2. This antibody recognizes human, mouse antigen. The SLC35F2 antibody has been validated for the following applications: ELISA, WB analysis.
